百济神州：2025年净利润扭亏为盈为14.22亿元，百悦泽®全球销售额为280.67亿元

Core Insights - The company reported a total revenue of 38.205 billion yuan for 2025, representing a 40.4% increase from 27.214 billion yuan in the previous year [1] - The net profit attributable to shareholders was 1.422 billion yuan, a significant improvement from a loss of 4.978 billion yuan in the same period last year [1] Revenue Growth - The global sales of Baiyueze® reached 28.067 billion yuan, marking a year-on-year growth of 48.8% [1] - The company has established a leading position in the BTK inhibitor market globally [1] Operational Efficiency - The company improved operational efficiency through revenue growth and cost management [1] - Successful profitability was achieved during the reporting period [1]